SCHEMBL19873503

SCHEMBL19873503

CN1CCCC1CCNc1nc(Nc2ccc(OC(F)(F)F)cc2)nc(C(Cl)(Cl)Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 3/20 0.46
▸ CAMK2D Q13557 1/20 0.45
▸ BACE1 P56817 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ PLK1 P53350 1/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ PLK3 Q9H4B4 1/20 0.42
▸ PLK2 Q9NYY3 1/20 0.42
▸ CHRM3 P20309 1/20 0.41
▸ HTR6 P50406 2/20 0.41
▸ GALR2 O43603 1/20 0.40
▸ ACP1 P24666 1/20 0.39
▸ ABL1 P00519 2/20 0.39
▸ BCR P11274 2/20 0.39
▸ GBA1 P04062 1/20 0.39
▸ RAD52 P43351 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSB P07858 1/20 0.38
▸ CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19873458 0.82 ABL1 (0.48) CHRNA7BACE1GALR2ABL1BCR
SCHEMBL19873454 0.82 CAMK2D (0.44) CAMK2DCCNA2CDK2PLK1CCNA1
SCHEMBL19873453 0.81 ABL1 (0.49) CHRNA7BACE1GALR2ACP1ABL1
SCHEMBL19873505 0.80 CAMK2D (0.42) CAMK2DACP1RAD52TERTNPC1
SCHEMBL19873488 0.78 GBA1 (0.50) ACP1GBA1
SCHEMBL19873515 0.77 CAMK2D (0.44) CAMK2DACP1GBA1RAD52TERT
SCHEMBL19873465 0.77 PIM1 (0.44) CHRNA7BACE1GALR2ABL1BCR
SCHEMBL19873518 0.77 CTSS (0.53) CHRNA7GALR2CTSLCTSBCTSS
SCHEMBL19873522 0.76 CHRNB4 (0.47) CAMK2DACP1GBA1
SCHEMBL19873491 0.75 CHRNA7 (0.53) CHRNA7BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351538-A1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS The United States of America, as represented by The Secretary of The Army, on behalf of Walter Reed Army Institute of Research (US) 2018-07-25 — — EP disclosed
EP-2970153-B1 TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS THE US SECRETARY OF THE ARMY ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) 2018-02-21 — — EP disclosed
Send feedback